4.1 Article

Plasmodium vivax hypoxanthine-guanine phosphoribosyltransferase: A target for anti-malarial chemotherapy

Journal

MOLECULAR AND BIOCHEMICAL PARASITOLOGY
Volume 173, Issue 2, Pages 165-169

Publisher

ELSEVIER SCIENCE BV
DOI: 10.1016/j.molbiopara.2010.05.018

Keywords

Plasmodium vivax; Purine salvage pathway; 6-Oxopurine phosphoribosyltransferase; Acyclic nucleoside phosphonates

Funding

  1. National Health and Medical Research Council, Australia [569703]
  2. Institute of Organic Chemistry and Biochemistry [AVOZ40550506]
  3. Centre for New Antivirals and Antineoplastics [1M0508]

Ask authors/readers for more resources

The malarial parasite. Plasmodium vivax (Pv), causes a serious infectious disease found primarily in Asia and the Americas. For protozoan parasites, 6-oxopurine phosphoribosyltransferases (PRTases) provide the only metabolic pathway to synthesize the purine nucleoside monophosphates essential for DNA/RNA production. We have purified the recombinant Pv 6-oxopurine (PRTase) and compared its properties with the human and Pf enzymes. The Pv enzyme uses hypoxanthine and guanine with similar catalytic efficiency to the Pf enzyme but xanthine is not a substrate, hence we identify this enzyme as PvHGPRT. Mass spectrometry suggests that PvHGPRT contains bound magnesium ions that are removed by EDTA resulting in loss of activity. However, the addition of Mg2+ restores activity. Acyclic nucleoside phosphonates (ANPs) are good inhibitors of PvHGPRT having K-i values as low as 3 mu M. These compounds can form the basis for the design of new drugs aimed at combating malaria caused by Pv. (C) 2010 Elsevier B.V. All rights reserved.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.1
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

Article Microbiology

Overcome Double Trouble: Baloxavir Marboxil Suppresses Influenza Thereby Mitigating Secondary Invasive Pulmonary Aspergillosis

Laura Seldeslachts, Cato Jacobs, Birger Tielemans, Eliane Vanhoffelen, Lauren Van der Sloten, Stephanie Humblet-Baron, Lieve Naesens, Katrien Lagrou, Erik Verbeken, Joost Wauters, Greetje Vande Velde

Summary: The study found that baloxavir marboxil has a therapeutic effect on influenza-associated pulmonary aspergillosis, improving body weight, survival, and viral clearance in a mouse model. It also reduces lung lesions and fungal burden, suggesting that baloxavir marboxil can mitigate severe influenza and decrease the risk of lethal invasive Aspergillus superinfection.

JOURNAL OF FUNGI (2022)

Review Chemistry, Multidisciplinary

FROM 5-AZAPYRIMIDINE CHEMISTRY TO THIADIAZOLES

Marcela Krecmerova

CHEMICKE LISTY (2022)

Article Physics, Multidisciplinary

Simultaneous Dual Echo Gadolinium Enhanced MR-PET for Evaluation of PET Tracer Delivery in Altered Pathophysiology

Gary J. Cowin, Karine Mardon, Zachary H. Houston, Rajiv Bhalla, Damion H. R. Stimson, Kristofer J. Thurecht, Ian M. Brereton

Summary: The study utilized dynamic gadolinium-enhanced magnetic resonance - positron emission tomography to independently evaluate vascular delivery and blood brain barrier integrity in brain tumors. It also observed the dynamic changes of therapeutic agents. This method can provide important information on the alterations of therapeutic agent delivery and uptake.

FRONTIERS IN PHYSICS (2022)

Article Chemistry, Medicinal

Synthesis of new N-(3-oxo-1-thia-4-azaspiro[4.5]decan-4-yl)pyridine-3-carboxamide derivatives and evaluation of their anti-influenza virus and antitubercular activities

Gokce Cihan-Ustundag, Cigdem Acar, Lieve Naesens, Gonca Erkose-Genc, Dilek Satana

Summary: We synthesized a novel series of hybrid spirothiazolidinone derivatives and evaluated their antiviral and antitubercular activities. Some of these compounds showed specific antiviral activity against the influenza A/H3N2 virus, with the most active compound being 3a with an antiviral EC50 value of 5.2μM. In addition, some compounds also exhibited inhibitory activity against Mycobacterium tuberculosis.

ARCHIV DER PHARMAZIE (2022)

Article Microbiology

Impact of SARS-CoV-2 Spike Mutations on Its Activation by TMPRSS2 and the Alternative TMPRSS13 Protease

Annelies Stevaert, Ria Van Berwaer, Cato Mestdagh, Julie Vandeput, Els Vanstreels, Valerie Raeymaekers, Manon Laporte, Lieve Naesens

Summary: The S2' motif in the SARS-CoV-2 spike protein plays a crucial role in spike activation, with TMPRSS2 showing more tolerance to variations than TMPRSS13. This insight will help in estimating the impact of S2' motif changes in new variants.
Article Pharmacology & Pharmacy

Development and optimization of biologically contained Marburg virus for high-throughput antiviral screening

Bert Vanmechelen, Joren Stroobants, Winston Chiu, Lieve Naesens, Joost Schepers, Kurt Vermeire, Piet Maes

Summary: This study successfully achieved biological containment of Marburg virus, demonstrating its feasibility for other filoviruses. By using genetic engineering and specific cell lines, the virus can be handled safely in lower biosafety settings.

ANTIVIRAL RESEARCH (2022)

Article Biochemistry & Molecular Biology

Synthesis and Anticancer and Antiviral Activities of C-2′-Branched Arabinonucleosides

Miklos Bege, Alexandra Kiss, Ilona Bereczki, Jan Hodek, Lenke Polyak, Gabor Szeman-Nagy, Lieve Naesens, Jan Weber, Aniko Borbas

Summary: In this study, d-arabinofuranosyl-pyrimidine and -purine nucleoside analogues containing alkylthio-, acetylthio- or 1-thiosugar substituents at the C2' position were synthesized by photoinitiated, radical-mediated hydrothiolation reactions. Some of these compounds exhibited selective cytotoxicity against tumor cells and also showed antiviral activity against SARS-CoV-2 and/or HCoV-229E.

INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2022)

Article Multidisciplinary Sciences

Semisynthetic teicoplanin derivatives with dual antimicrobial activity against SARS-CoV-2 and multiresistant bacteria

Ilona Bereczki, Vladimir Vimberg, Eszter Lorincz, Henrietta Papp, Lajos Nagy, Sandor Keki, Gyula Batta, Ana Mitrovic, Janko Kos, Aron Zsigmond, Istvan Hajdu, Zsolt Lorincz, David Bajusz, Laszlo Petri, Jan Hodek, Ferenc Jakab, Gyorgy M. Keseru, Jan Weber, Lieve Naesens, Pal Herczegh, Aniko Borbas

Summary: Patients infected with SARS-CoV-2 are at risk of co-infection with Gram-positive bacteria, which greatly affects their prognosis. Antimicrobial drugs with dual antiviral and antibacterial activity would be valuable in this context. The researchers synthesized and evaluated seven derivatives of teicoplanin, a glycopeptide antibiotic, with hydrophobic or superbasic side chains. Except for one derivative, all teicoplanin derivatives effectively inhibited SARS-CoV-2 replication in VeroE6 cells. Some of these derivatives also showed activity against HCoV-229E, a human coronavirus, in human Calu-3 cells. The study revealed that the teicoplanin derivatives efficiently prevented the entry of SARS-CoV-2 into cells through both endosomal and surface entry routes. Moreover, these derivatives exhibited good to excellent activity against Gram-positive bacteria resistant to glycopeptide antibiotics.

SCIENTIFIC REPORTS (2022)

Article Chemistry, Medicinal

A Versatile Class of 1,4,4-Trisubstituted Piperidines Block Coronavirus Replication In Vitro

Sonia De Castro, Annelies Stevaert, Miguel Maldonado, Adrien Delpal, Julie Vandeput, Benjamin Van Loy, Cecilia Eydoux, Jean-Claude Guillemot, Etienne Decroly, Federico Gago, Bruno Canard, Maria-Jose Camarasa, Sonsoles Velazquez, Lieve Naesens

Summary: There is a need for novel antiviral concepts to control SARS-CoV-2 infection. A class of 1,4,4-trisubstituted piperidines have shown promising anti-coronavirus activity. Several analogues were synthesized and evaluated, and four molecules demonstrated micromolar activity against SARS-CoV-2. These compounds were found to inhibit the main protease (M-pro) of SARS-CoV-2, suggesting they could serve as non-covalent inhibitors for further development.

PHARMACEUTICALS (2022)

Article Virology

Nucleoside analogs for management of respiratory virus infections: mechanism of action and clinical efficacy

Annelies Stevaert, Elisabetta Groaz, Lieve Naesens

Summary: The COVID-19 pandemic has accelerated the development of nucleoside analogs for treating respiratory virus infections. Remdesivir is the first authorized compound, and three other nucleoside analogs are in the pipeline. This article summarizes the current knowledge on their clinical efficacy and mentions trials for influenza and respiratory syncytial virus. Furthermore, it outlines how nucleoside analogs interact with respiratory virus polymerases to cause lethal virus mutagenesis or disturbance of viral RNA synthesis.

CURRENT OPINION IN VIROLOGY (2022)

Article Agriculture, Multidisciplinary

Crystal Structure of the Commercial Herbicide, Amidosulfuron, in Complex with Arabidopsis thaliana Acetohydroxyacid Synthase

Yan Cheng, Thierry Lonhienne, Mario D. Garcia, Craig M. Williams, Gerard Schenk, Luke W. Guddat

Summary: Amidosulfuron (AS), a commercial sulfonylurea herbicide, effectively targets dicot broadleaf weeds by inhibiting acetohydroxyacid synthase (AHAS) in the plants. The crystal structure analysis shows that AS lacks a second aromatic ring compared to other AHAS-inhibiting herbicides, but still exhibits potent herbicidal activity through accumulative inhibition. This study highlights the importance of accumulative inhibition in designing effective herbicides targeting plant AHAS.

JOURNAL OF AGRICULTURAL AND FOOD CHEMISTRY (2023)

Article Pharmacology & Pharmacy

PRO-2000 exhibits SARS-CoV-2 antiviral activity by interfering with spike-heparin binding

Evelien Vanderlinden, Arnaud Boonen, Sam Noppen, Geert Schoofs, Maya Imbrechts, Nick Geukens, Robert Snoeck, Annelies Stevaert, Lieve Naesens, Graciela Andrei, Dominique Schols

Summary: PRO-2000, a sulfonated polyanionic compound, has anti-SARS-CoV-2 activity by blocking the entry pathway and inhibiting the binding of the S protein to its receptor. It can potentially inhibit a broad range of SARS-CoV-2 variants.

ANTIVIRAL RESEARCH (2023)

Article Chemistry, Medicinal

Exploration of 1,2,3-triazolo fused triterpenoids as inhibitors of human coronavirus 229E targeting the viral nsp15 protein

Rui Wang, Annelies Stevaert, Tien Nguyen Truong, Qifei Li, Besir Krasniqi, Benjamin Van Loy, Arnout Voet, Lieve Naesens, Wim Dehaen

Summary: The study investigates the structure-activity relationship of novel coronavirus inhibitors and identifies a class of 1,2,3-triazolo fused triterpenoid compounds with strong antiviral activity against HCoV-229E.

ARCHIV DER PHARMAZIE (2023)

Article Biochemistry & Molecular Biology

Discovery of a potent and selective human AC2 inhibitor based on 7-dea- zapurine analogues of adefovir

Pavel Kraina, Michal Cesnek, Eva Tloustova, Helena Mertlikova-Kaiserova, Camryn J. Fulton, Emily K. Davidson, Brenton P. Smith, Val J. Watts, Zlatko Janeba

Summary: A series of novel 7-substituted 7-deazaadefovir analogues were synthesized, and 12 of them were found to be single-digit micromolar inhibitors of Bordetella pertussis adenylate cyclase toxin. Compound 14 was identified as a potent, non-toxic, and selective mAC2 inhibitor.

BIOORGANIC & MEDICINAL CHEMISTRY (2023)

Meeting Abstract Cardiac & Cardiovascular Systems

Immunological Overlap Between Rejection and Infection in Murine Lung Transplantation

J. Kaes, E. Vanhulle, L. Seldeslachts, C. Hooft, H. Beeckmans, X. Jin, P. Kerckhof, J. Van Slambrouck, D. Van Raemelonck, G. Vande Velde, L. Naesens, D. Schols, L. J. Ceulemans, R. Vos, K. Vertneire, B. M. Vanaudenaerde

JOURNAL OF HEART AND LUNG TRANSPLANTATION (2023)

No Data Available